{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:04:31Z","timestamp":1787785471933,"version":"build-2784847793"},"reference-count":61,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T00:00:00Z","timestamp":1548460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT989-16"],"award-info":[{"award-number":["IT989-16"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EiTB maratoia","award":["BIO15\/CA\/022"],"award-info":[{"award-number":["BIO15\/CA\/022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Diffuse large B cell lymphoma (DLBCL) is the most common subtype of invasive non-Hodgkin\u2019s lymphoma (NHL). DLBCL presents with variable backgrounds, which results in heterogeneous outcomes among patients. Although new tools have been developed for the classification and management of patients, 40% of them still have primary refractory disease or relapse. In addition, multiple factors regarding the pathogenesis of this disease remain unclear and identification of novel biomarkers is needed. In this context, recent investigations point to microRNAs as useful biomarkers in cancer. The aim of this systematic review was to provide new insight into the role of miRNAs in the diagnosis, classification, treatment response and prognosis of DLBCL patients. We used the following terms in PubMed\u201d ((\u2018Non-coding RNA\u2019) OR (\u2018microRNA\u2019 OR \u2018miRNA\u2019 OR \u2018miR\u2019) OR (\u2018exosome\u2019) OR (\u2018extracellular vesicle\u2019) OR (\u2018secretome\u2019)) AND (\u2018Diffuse large B cell lymphoma\u2019 OR \u2018DLBCL\u2019)\u201d to search for studies evaluating miRNAs as a diagnosis, subtype, treatment response or prognosis biomarkers in primary DLBCL in human patient populations. As a result, the analysis was restricted to the role of miRNAs in tumor tissue and we did not consider circulating miRNAs. A total of thirty-six studies met the inclusion criteria. Among them, twenty-one were classified in the diagnosis category, twenty in classification, five in treatment response and nineteen in prognosis. In this review, we have identified miR-155-5p and miR-21-5p as miRNAs of potential utility for diagnosis, while miR-155-5p and miR-221-3p could be useful for classification. Further studies are needed to exploit the potential of this field.<\/jats:p>","DOI":"10.3390\/cancers11020144","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T03:40:55Z","timestamp":1548733255000},"page":"144","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma"],"prefix":"10.3390","volume":"11","author":[{"given":"Ane","family":"Larrabeiti-Etxebarria","sequence":"first","affiliation":[{"name":"Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"},{"name":"Pharmacy Service, Araba University Hospital-Txagorritxu, 01009 Vitoria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lopez-Santillan","sequence":"additional","affiliation":[{"name":"Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"},{"name":"Medical Oncology Service, Basurto University Hospital, 48013 Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Santos-Zorrozua","sequence":"additional","affiliation":[{"name":"Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-3031","authenticated-orcid":false,"given":"Elixabet","family":"Lopez-Lopez","sequence":"additional","affiliation":[{"name":"Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"},{"name":"BioCruces Health Research Institute, 48903 Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Africa","family":"Garcia-Orad","sequence":"additional","affiliation":[{"name":"Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV\/EHU), 48940 Leioa, Spain"},{"name":"BioCruces Health Research Institute, 48903 Barakaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/2278-330X.126531","article-title":"Management of relapsed-refractory diffuse large B cell lymphoma","volume":"3","author":"Raut","year":"2014","journal-title":"South Asian J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993). A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N. Engl. J. Med., 329, 987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"22850","DOI":"10.18632\/oncotarget.25230","article-title":"Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review","volume":"9","year":"2018","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/epi-2017-0138","article-title":"Pharmacoepigenetics in childhood acute lymphoblastic leukemia: Involvement of miRNA polymorphisms in hepatotoxicity","volume":"10","author":"Umerez","year":"2018","journal-title":"Epigenomics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: Annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fonc.2018.00226","article-title":"Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors","volume":"8","author":"Hahne","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1007\/s00018-018-2877-x","article-title":"Overview upon miR-21 in lung cancer: Focus on NSCLC","volume":"75","author":"Magdo","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Linehan, W.M., Spellman, P.T., Ricketts, C.J., Creighton, C.J., Fei, S.S., Davis, C., Wheeler, D.A., Murray, B.A., and Schmidt, L. (2015). Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N. Engl. J. Med., 374, 135\u2013145.","DOI":"10.1056\/NEJMoa1505917"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e11213","DOI":"10.1097\/MD.0000000000011213","article-title":"The prognostic value of microRNA-183 in human cancers: A meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"key":"ref_17","first-page":"5153","article-title":"MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3\/JAK-STAT3 signaling pathway","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/leu.2017.299","article-title":"HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma","volume":"32","author":"Jia","year":"2017","journal-title":"Leukemia"},{"key":"ref_19","first-page":"4489","article-title":"MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2","volume":"14","author":"Liu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12032-014-0919-2","article-title":"MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma","volume":"31","author":"Wang","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2014.04.002","article-title":"Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"45","author":"Wu","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_22","first-page":"334","article-title":"miR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma","volume":"41","author":"Tamaddon","year":"2016","journal-title":"Iran. J. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/1354750X.2015.1068855","article-title":"Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP","volume":"20","author":"Ni","year":"2015","journal-title":"Biomarkers"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12185-015-1847-4","article-title":"Oncogenic microRNA-155 and its target PU.1: An integrative gene expression study in six of the most prevalent lymphomas","volume":"102","author":"Huskova","year":"2015","journal-title":"Int. J. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.3390\/ijms160818077","article-title":"miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients","volume":"16","author":"Troppan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.18632\/oncotarget.3729","article-title":"MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K\/AKT pathway in diffuse large B-cell lymphoma","volume":"6","author":"Go","year":"2015","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13059-014-0568-y","article-title":"Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients","volume":"16","author":"Lim","year":"2015","journal-title":"Genome Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1038\/bcj.2013.49","article-title":"Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma","volume":"3","author":"Caramuta","year":"2013","journal-title":"Blood Cancer J."},{"key":"ref_29","first-page":"14","article-title":"Investigating the Expression of Oncogenic and Tumor Suppressive MicroRNA in DLBCL","volume":"39","author":"Handal","year":"2013","journal-title":"J. Assoc. Genet. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/etm.2012.502","article-title":"Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed\/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma","volume":"3","author":"Zhong","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/labinvest.2012.129","article-title":"The miR-17-92 microRNA cluster: A novel diagnostic tool in large B-cell malignancies","volume":"92","author":"Fassina","year":"2012","journal-title":"Lab. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"Microrna expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma","volume":"121","author":"Lawrie","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s13238-016-0316-z","article-title":"miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma","volume":"7","author":"Fan","year":"2016","journal-title":"Protein Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e7952","DOI":"10.1097\/MD.0000000000007952","article-title":"Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma","volume":"96","author":"Song","year":"2017","journal-title":"Medicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3892\/or.2012.2173","article-title":"High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma","volume":"29","author":"Berglund","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1073\/pnas.1200081109","article-title":"MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03baB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2353\/ajpath.2010.091291","article-title":"Epigenetic down-regulation of the tumor suppressor gene PRDM1\/Blimp-1 in diffuse large B cell lymphomas: A potential role of the microRNA let-7","volume":"177","author":"Nie","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exphem.2015.12.007","article-title":"High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma","volume":"44","author":"Marques","year":"2016","journal-title":"Exp. Hematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B-cell differentiation","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2012.03.013","article-title":"Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma","volume":"181","author":"Huang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2010-11-321554","article-title":"miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy","volume":"118","author":"Martinez","year":"2011","journal-title":"Blood"},{"key":"ref_46","first-page":"415","article-title":"MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma","volume":"24","author":"Zhu","year":"2016","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.leukres.2015.03.018","article-title":"MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma","volume":"39","author":"Shepshelovich","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","article-title":"MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP","volume":"17","author":"Alencar","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2008-10-184077","article-title":"Differentiation stage\u2013specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas","volume":"113","author":"Malumbres","year":"2009","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Testa, U., Pelosi, E., Castelli, G., and Labbaye, C. (2017). miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development. Noncoding RNA, 3.","DOI":"10.3390\/ncrna3030022"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/onc.2011.293","article-title":"FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells","volume":"31","author":"McInnes","year":"2011","journal-title":"Oncogene"},{"key":"ref_52","first-page":"1615","article-title":"Early diagnostic role of PSA combined miR-155 detection in prostate cancer","volume":"22","author":"Guo","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/emmm.200900028","article-title":"Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas","volume":"1","author":"Pedersen","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"44893","DOI":"10.18632\/oncotarget.16488","article-title":"The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: A systematic review and meta-analysis","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: How a complex biology gets more complex","volume":"29","author":"Musilova","year":"2014","journal-title":"Leukemia"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Stramucci, L., Pranteda, A., and Bossi, G. (2018). Insights of Crosstalk between p53 Protein and the MKK3\/MKK6\/p38 MAPK Signaling Pathway in Cancer. Cancers, 10.","DOI":"10.3390\/cancers10050131"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10428194.2014.917639","article-title":"Dual inhibition of phosphatidylinositol 3-kinase\/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma","volume":"56","author":"Anders","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nmeth.3485","article-title":"miRWalk2.0: A comprehensive atlas of microRNA-target interactions","volume":"12","author":"Dweep","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.1093\/nar\/gks1055","article-title":"The ConsensusPathDB interaction database: 2013 update","volume":"41","author":"Kamburov","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","article-title":"The Reactome pathway Knowledgebase","volume":"44","author":"Fabregat","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/2\/144\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:28:51Z","timestamp":1760185731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/2\/144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,26]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["cancers11020144"],"URL":"https:\/\/doi.org\/10.3390\/cancers11020144","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,26]]}}}